SAN DIEGO CANCER RESEARCH INSTITUTE (EIN 330970245) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

CLAUDIO A GARCIA

Phone

7605981700

Tax Period

2023-01-01 to 2023-12-31

SAN DIEGO CANCER RESEARCH INSTITUTE, founded in 2001, is a micro nonprofit in the Medical Research sector that reported $17K in total revenue in fiscal year 2023. Revenue surged 173% from the prior year, signaling strong growth momentum. Expenses of $16K left a modest 8% surplus.

Mission

SAN DIEGO CANCER RESEARCH INSTITUTE IS ENGAGED IN HELPING CANCER PATIENTS GAIN QUICK ACCESS TO STATE-OF-THE-ART MEDICAL TREATMENT, AND TO PROVIDE THEM WITH OPTIMAL PHYSICAL, EMOTIONAL AND SPIRITUAL GUIDANCE TO CHALLENGE THEIR ILLNESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,460

Program Service Revenue $0

Investment Income $15,653

Other Revenue $0

TOTAL REVENUE $17,113

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $9,795

Other Expenses $15,724

TOTAL EXPENSES $15,724

Year-over-Year Comparison

	2023	2022	Change
Revenue	$17,113	$6,277	+1.7%
Expenses	$15,724	$25,186	-0.4%
Net Income	$1,389	$-18,909	-1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
DANIEL VICARIO	PROGRAM-BOARD MEMBER	Director	$0	$0	$0
RONALD L SMITH	BOARD MEMBER	Director	$0	$0	$0
MARK J ADLER	CHIEF EXECUTIVE OFFICER	Officer Director	$0	$0	$0
CLAUDIO GARCIA	CHIEF FINANCIAL OFFICER	Officer	$0	$0	$0
LORI S VARAICH	CHIEF LEGAL OFFICER	Officer	$0	$0	$0
PENBY AU	STAFF ACCOUNTANT	Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$17,113	$15,724	$380,518	$1,389
2022	$6,277	$25,186	$379,129	$-18,909
2021	$6,446	$29,014	$398,038	$-22,568
2020	$5,612	$22,309	$420,606	$-16,697
2019	$30,037	$24,306	$437,303	$5,731
2018	$18,293	$76,391	$431,572	$-58,098

SAN DIEGO CANCER RESEARCH INSTITUTE